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Dr Parkt
doi:10.1016/j.jtcvs.2006.09.022bjective: The objective was to define the incidence of atrial fibrillation after
ideo-assisted thoracic surgery lobectomy and determine whether video-assisted
horacic surgery reduces atrial fibrillation rate compared with thoracotomy.
ethods: With the use of a single-institution database of patients who underwent
obectomy for clinical stage I non–small cell lung cancer, 389 patients were
dentified who were in sinus rhythm preoperatively and received no prophylactic
ntiarrhythmics. Patients undergoing video-assisted thoracic surgery were age and
ender matched with those undergoing thoracotomy.
esults: After matching, 122 patients undergoing video-assisted thoracic surgery
nd 122 patients undergoing thoracotomy were eligible for analysis. Patients un-
ergoing video-assisted thoracic surgery had a higher preoperative diffusion capac-
ty (92%  28% vs 80%  18% predicted, P  .001) and a lower rate of induction
hemotherapy (5/122, 4% vs 11/122, 11%, P  .05) than patients undergoing
horacotomy. Atrial fibrillation occurred in 12% of patients (15/122) undergoing
ideo-assisted thoracic surgery and 16% of patients (20/122) undergoing thoracot-
my (P  .36). Overall, complications were lower in the video-assisted thoracic
urgery group (17.2% vs 27.9%, P  .046). Patients with atrial fibrillation were
lder in both video-assisted thoracic surgery (73  7 years vs 66  9 years, P 
002) and thoracotomy groups (72  7 years vs 66  10 years, P  .005). Length
f stay for patients with atrial fibrillation was greater in both video-assisted thoracic
urgery (6.0  1.5 days vs 4.7  2.5 days, P  .01) and thoracotomy groups (9.2
4.3 days vs 6.8  3.6 days, P  .03).
onclusions: Regardless of surgical approach, atrial fibrillation after lobectomy
ccurred with equal frequency. This supports the theory that autonomic denervation
nd stress-mediated neurohumoral mechanisms are responsible for the pathogenesis
f postoperative atrial fibrillation. Prophylaxis regimens against atrial fibrillation
hould be the same for either operative approach.
ostoperative atrial arrhythmias, in particular atrial fibrillation (AF), are seen
in more than 20% of elderly patients undergoing noncardiac thoracic sur-
gery.1 Postoperative AF is commonly associated with other complications,
esulting in increased hospital stay and costs, as well as greater risk of stroke in
hose who remain in persistent AF.1,2 Advanced age (60 years) is the independent
isk factor most strongly and consistently associated with postoperative AF.1-3 Fifty
ercent of patients with non–small cell lung cancer (NSCLC) are aged more than 65
ears, whereas more than 30% are at least 70 years old at diagnosis.4,5 This,
ombined with the fact that the proportion of individuals aged more than 65 years
n the United States is increasing, suggests that the number of elderly patients with
ung cancer requiring major thoracic surgical procedures will continue to increase in
he future.6

































































































General Thoracic Surgery Park et al
7
G
TSThe technique of video-assisted thoracic surgery (VATS)
ulmonary lobectomy for NSCLC was first reported in the
arly 1990s simultaneously by several authors.7-10 When
sed with a non–rib spreading technique, a VATS approach
as been shown to be associated with a shorter hospital stay
nd decreased acute postoperative pain.10,11 Because of this
nd indications that the procedure is safe and oncologically
cceptable in patients with clinical stage I disease, the use of
ATS lobectomy for primary surgical therapy of early-
tage NSCLC has been slowly increasing.12-17 There is also
belief that the use of a minimally invasive VATS tech-
ique may result in superior rates of postoperative morbid-
ty when compared with thoracotomy, especially in elderly
r high-risk populations.18,19
However, relatively few studies have analyzed in detail
he incidence of postoperative AF after VATS lobectomy or
hether this rate is decreased in these patients when com-
ared with those undergoing thoracotomy. We decided to
erform a case-control study analyzing the rates of postop-
rative arrhythmia in patients undergoing lobectomy to de-
ermine whether there is an advantage afforded by the
inimally invasive VATS approach.
atients and Methods
fter approval by the institutional review board and waiver of
nformed consent, a prospectively maintained database of all pa-
ients undergoing thoracic surgery for lung cancer at a single
nstitution was used to identify all patients who underwent elective
ulmonary lobectomy for clinical stage I NSCLC and were in
inus rhythm preoperatively. Excluded were patients who were not
n sinus rhythm before surgery, taking class I or III antiarrhythmic
rugs, or placed on prophylactic medications postoperatively. In-
ividuals already taking preoperative beta-blockers or calcium
hannel blockers for hypertension or coronary artery disease were
esumed on the first postoperative day to avoid withdrawal and
ere not excluded. Also excluded were patients who underwent a
esser resection (exploration, wedge or segmentectomy) or more
xtensive operation (bilobectomy, pneumonectomy, chest wall re-
ection, or major vascular resection).
Standard anesthesia induction and maintenance regimens and
ntraoperative fluid restriction were used for all patients. Postop-
rative pain relief was provided by continuous administration of
pidural opioid (usually fentanyl with bupivacaine 0.05%) admin-
stration. In all patients, anatomic pulmonary lobectomy and ipsi-
ateral mediastinal lymph node dissection were performed either
y VATS or standard posterolateral thoracotomy. VATS lobec-
omy was defined as anatomic pulmonary lobectomy using a video
Abbreviations and Acronyms
AF  atrial fibrillation
NSCLC non–small cell lung cancer
VATS  video-assisted thoracic surgeryhoracoscope and 3 non–rib spreading incisions, the largest of a
76 The Journal of Thoracic and Cardiovascular Surgery ● Marchich was a 3- to 4-cm utility incision. Patients converted from
ATS for whatever reason were considered to be in the thoracot-
my group. All patients remained overnight in the postanesthesia
are unit on continuous telemetry and were then discharged to a
edicated thoracic surgical ward on the first postoperative day.
hen available, continuous telemetry was continued on the ward
or an additional 48 hours or longer as needed. If the patient
emained in normal sinus rhythm for 72 hours postoperatively,
elemetry was discontinued. Data on patient characteristics, oper-
tive details, and postoperative recovery were collected in a pro-
pective database approved by the institutional review board and
nalyzed retrospectively. All complications were graded according
o the National Cancer Institute Common Terminology Criteria for
dverse Events version 3.0 (http://ctep.cancer.gov/reporting/
tc.html). AF was defined by an irregular rhythm with absent P
aves confirmed by 12-lead electrocardiography. Episodes of AF
ypically were identified by continuous telemetry or 12-lead elec-
rocardiography performed because of clinically detected tachy-
ardia. Patients were considered to have AF if the episode lasted
ore than 5 minutes by continuous telemetry or required interven-
ion because of rapid ventricular response, presence of symptoms,
r hemodynamic compromise.
Patients were matched on the basis of age and gender. Differ-
nces between the VATS and thoracotomy groups were assessed
y the Student t, chi-square, or Fisher exact tests where appropri-
te. Data are presented as mean value  standard deviation unless
therwise indicated. Statistical analysis was performed with the
tatistical Package for the Social Sciences version 12.0 (SPSS Inc,
hicago, Ill).
esults
atient Characteristics and Atrial Fibrillation Rate
review of the prospective database of thoracic surgical
ases performed from January 1999 to June 2004 identified
89 patients who were in sinus rhythm preoperatively, un-
erwent elective lobectomy, and received no prophylactic
ntiarrhythmic medications. Of these patients, 267 under-
ent thoracotomy and 122 had a VATS approach. After age
nd gender matching, there were 244 patients eligible for
nalysis, 122 in each group. The patients in each group were
ell matched with respect to preoperative characteristics
Table 1). The VATS group had a slightly higher preoper-
tive carbon monoxide diffusion in the lung, and a higher
ercentage of patients in the thoracotomy group received
reoperative chemotherapy. The presence of comorbid con-
itions, preoperative serum electrolyte values, and the pro-
ortion of patients taking beta-blockers or calcium channel
lockers in each group were similar. The operative time was
lightly longer in the VATS group (3.7  1.0 hours vs 3.0
1.0 hours, P  .001).
Because of limited availability, continuous telemetry on
ransfer from the postanesthesia care unit was used in 23%
f patients (57/244), with no difference between groups
25% VATS vs 22% thoracotomy, P  .76). The overall
ate of postoperative AF in all patients was 14% (35/244),
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G
TSal approach (Table 2). AF was observed in 20 of 122
atients (16%) who underwent thoracotomy and lobectomy
ompared with 15 of 122 patients (12%) who underwent
ATS lobectomy (P  .36). Among patients who were 60
ears and older, AF occurred in 15 of 100 (15%) in the
ATS group and in 18 of 100 (18%) in the thoracotomy
roup (P  .57). A similar proportion of patients on telem-
try in the VATS and thoracotomy groups had AF (27% vs








ge, y 67 10 67  10 .99
ange, y 38-85 37-85
ale/female, n 38/84 38/84 .99
reoperative chemotherapy, n
(%)
5 (4) 13 (11) .05
OPD, n (%) 25 (21) 33 (27) .23
TN, n (%) 46 (38) 40 (33) .42
I, n (%) 4 (3) 4 (3) .99
AD, n (%) 12 (9.8) 11 (9.0) 1.0
M, n (%) 10 (8) 9 (7) .81
EV1% predicted 90  19 86  14 .09
LCO% predicted 92 28 80  18 .001
reoperative serum potassium
(mEq/L)
4.3  0.4 4.4  0.4 .49
reoperative serum calcium
(mg/dL)
9.3  0.5 9.3  0.6 .94
reoperative -blocker, n (%) 25 (20) 26 (21) 1.0
reoperative Ca2 channel
blocker, n (%)
14 (12) 16 (13) .85
uration of surgery (h) 3.7 1.0 3.0  1.0 .001
elemetry, n (%) 30 (25) 27 (22) .76
OPD, Chronic obstructive pulmonary disease; HTN, hypertension; MI,
yocardial infarction; CAD, coronary artery disease; DM, diabetes melli-
us; FEV1, forced expiratory volume in 1 second; DLCO, carbon monoxide
iffusion in the lung; VATS, video-assisted thoracic surgery; THOR, thora-
otomy. Data are mean  standard deviation or n (%).
ABLE 2. Postoperative complications
VATS THOR
eature (n  122) (n  122) P value
F rate (%) 15/122 (12%) 20/122 (16%) .36
telectasis, n 2 (1.6%) 5 (4.1%) .28
rolonged air leak, n 4 (3.8%) 7 (5.7%) .54
neumothorax, n 1 (0.8%) 3 (2.5%) .62
neumonitis, n 2 (1.6%) 5 (4.1%) .28
otal, n (%) 21 (17.2) 34 (27.9) .046
OS, d 4.9 2.4 7.2 3.8 .001
eaths*, n (%) 0 (0%) 3 (2.5%) .25
F, Atrial fibrillation/flutter; LOS, length of stay; VATS, video-assisted
horacic surgery; THOR, thoracotomy. *Within 30 days of surgery. Total
omplication rate includes patients who had 1 or more events. Data aresean  standard deviation or n (%).
The Journal of Thoracic3%). In addition, there were no differences in the presence
f comorbid conditions, the preoperative serum electrolyte
alues, the proportion of patients taking beta-blockers or
alcium channel blockers, or the operative time between
atients who did and did not have AF (data not shown).
ine of the patients with AF had another complication as
ell.
erioperative Morbidity and Outcomes
total of 55 of 244 patients (23%) had 1 or more postop-
rative complications, with a significantly lower complica-
ion rate in the VATS group (17.2% in the VATS group vs
7.9% in the thoracotomy group, P  .046). There was no
ifference in the perioperative 30-day mortality rates be-
ween the 2 groups, although there were no deaths in the
ATS group. The mean length of hospital stay of the
atients who underwent thoracotomy was more than 2 days
reater than that of the patients who underwent VATS (7.2
3.8 days vs 4.9  2.4 days, P  .001). Moreover, the
ength of hospital stay was significantly greater for patients
ith AF compared with patients who did not have AF both
ithin the VATS cohort (6.0  1.5 days vs 4.7  2.5 days,
 .01) and the thoracotomy cohort (9.2  4.3 days vs 6.8
 3.6 days, P  .03) (Table 3). Patients with AF were older
han those without AF regardless of whether they had a
ATS approach (73  7 years vs 66  9 years, P  .002)
r a thoracotomy (72  7 years vs 66  10 years, P 
005).
iscussion
he main finding of the present study is that postoperative
F after pulmonary lobectomy occurs with similar fre-
uency whether a minimally invasive VATS or a traditional
ib-spreading thoracotomy is performed. The overall rate of
F in all patients was 14%, a figure consistent with that
een in previous series mentioned above,20-22 and after
atching for age and gender there was no difference be-
ween patients who underwent VATS and patients who
nderwent thoracotomy. The precise cause of AF in these
atients is still unclear, but the results suggest that auto-
omic denervation and stress-mediated neurohumoral
echanisms resulting from anatomic pulmonary resection,
nd not incision-related effects, are responsible for the
athogenesis of AF in susceptible individuals.1,20 As noted
n prior studies,1-3,20-22 although AF frequently accompa-
ies other comorbidities postoperatively, AF contributes to
longer hospitalization when compared with patients with-
ut AF undergoing the same operative approach.
Proponents of VATS for anatomic lung resection empha-
ize the benefits of decreased acute postoperative pain,
horter chest tube duration, and, consequently, shorter hos-
ital stays. In addition, some authors have attempted to
how that a less-invasive approach to lung resection results
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G
TSn fewer postoperative complications in high-risk patients,
uch as the elderly who might not otherwise tolerate thora-
otomy.18,19 One of the most common postoperative com-
lications after anatomic pulmonary resection is supraven-
ricular arrhythmia, an event that results in an extended
ospital stay with the attendant increased costs, as well as a
reater risk of stroke.1,2 In several large retrospective stud-
es that analyzed the incidence of and risk factors for post-
perative AF after noncardiac thoracic surgical procedures,
he observed rate was approximately 20%.20-22 The pre-
erred surgical approach in the majority of these studies was
horacotomy. In contrast, Jaklitsch and colleagues18 re-
orted that the AF rate in 32 elderly patients undergoing
ATS lobectomy was 3.1%, whereas Gharagozloo and col-
eagues23 reported an arrhythmia rate of 9.4% (17/179).
cKenna and colleagues24 published the largest single in-
titution series of 1100 VATS lobectomies and reported a
ostoperative AF rate of 2.9%. These data suggest that a
inimally invasive VATS technique, perhaps by obviating
he surgical stress induced by a rib-spreading thoracotomy,
ay result in a decreased incidence of AF. The greater
ncidence of AF observed in our study may be explained by
ifferences in AF definitions, monitoring techniques, and
revention strategies in each of the referenced studies. We
ecently observed that elderly patients undergoing a lobec-
omy have an incidence of AF of 27% when telemetry is
sed.25 Because of logistic constraints, our study used rou-
ine continuous telemetry in 23% of patients; as a result, we
elieve that our reported incidence of AF is actually an
nderestimate of the true rate and that we were unable to
etect asymptomatic or “silent” episodes that required no
ntervention.
There were a few interesting trends when comparing
he VATS and thoracotomy groups with regard to other
spects of their postoperative course. As expected and
onsistent with numerous previous reports, the length of
ospital stay for patients undergoing VATS was signifi-
antly shorter than their thoracotomy counterparts by
ore than 2 days. This in part explains why the mean
uration of hospitalization for patients undergoing VATS
obectomy who had AF was still shorter than that of
atients undergoing thoracotomy without AF (6.0  1.5
ays vs 6.8  3.6 days). The trend in the number and rate
f overall and major pulmonary complications seemed to
ABLE 3. Impact of atrial fibrillation on hospital stay
VATS/AF, n  15 VATS/No AF, n  107 P
ge (y) 73 7 66 9
OS (d) 6.0 1.5 4.7 2.5
OS, Length of stay; VATS, video-assisted thoracic surgery; AF, atrial fibravor the VATS group, but this result did not reach
78 The Journal of Thoracic and Cardiovascular Surgery ● Marctatistical significance. Additional studies looking into
his issue with a larger sample size might be useful.
trengths and Limitations
here are several strengths of this study. First, we evaluated
common postoperative problem after anatomic lung re-
ection in a homogeneous population of patients. Second,
he definition and detection of the end point of AF was
ystematic, consistent, and clinically relevant. Third, by
atching patients we attempted to eliminate selection bias
s rigorously as possible outside of the setting of a random-
zed, prospective study. There are also several limitations.
irst, as mentioned above, telemetry was not routinely used
n all patients once patients were discharged from the post-
nesthesia care unit. Second, despite matching, this is still a
etrospective analysis, and there were inequalities between
roups that were both known (use of induction therapy and
reoperative carbon monoxide diffusion in the lung) and
nknown. Third, it is possible that the sample size studied
as not large enough to show that the 4% difference in AF
ate was statistically significant. However, to discern a
ifference between a proportion of 0.12 and 0.16 in the
inomial 2-sample case at an alpha of 0.5 and power of 0.8,
study with 1180 patients in each group would be required.
ast, although the results suggest that the operative ap-
roach is not a significant factor in the pathogenesis of
ostoperative AF, the data offer little additional insight to
urther our understanding of mechanisms responsible for
ostoperative AF.
onclusions
F is a common postoperative complication in older pa-
ients undergoing anatomic pulmonary resection and con-
ributes to prolonged hospitalization, associated health care
osts, and the known risk for thromboembolic events. The
se of a minimally invasive, non–rib spreading VATS ap-
roach does not decrease the incidence of postoperative AF
hen compared with standard thoracotomy. Patients
eemed to be high risk preoperatively should be considered
or proven prophylactic therapy regardless of the planned
perative approach.25,26
eferences
THOR/AF, n  20 THOR/No AF, n  102 P value
72 7 66 10 .005
9.2 4.3 6.8  3.6 .03
; THOR, thoracotomy. Data are mean  standard deviation.value
.002
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